Skip to main content

Advaita, LifeMap Sign Software Marketing Agreement

NEW YORK (GenomeWeb) – Today, Advaita Bioinformatics announced a partnership with BioTime subsidiary LifeMap Sciences to promote and sell iPathwayGuide, Advaita's flagship genomic data analysis product.

Under the terms of the agreement, iPathwayGuide will be featured across several LifeMap products, including GeneCards, which is a reference database of human genes. Advaita's iPathway is a web-based application for analyzing information from next-generation sequencing and gene expression experiments and identifying the genetic pathways that are affected in disease. Customers of the solution are allowed to upload and analyze their data and view the results for free for 72 hours. They can then purchase a single report or pay a fee for unlimited access to the results.

The arrangement with LifeMap will "expose the usefulness and advance capabilities of iPathwayGuide to hundreds of thousands of LifeMaps’ users," Sorin Draghici, Advaita's president and CEO, said in a statement.  "We have already seen incredible interest [in] our software and this collaboration will continue to bring awareness of its advantages, as well as benefit the current LifeMap users."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.